SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AutoImmune-AIMM

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Lachot who wrote (130)6/2/1997 11:57:00 AM
From: Zeev Hed   of 298
 
Don: In view of the extreme negative feelings on this thread, it is time (for me) to take a gamble on this one, I like stocks selling under book value and at discount to cash. The new research actually will put some money in their pocket since it is fully funded by NIH.

The big question about oral tolerance is still open. They certainly believe in it, and I have no idea if it works or not, but after having sold last year at 9.75 (and unfortunately almost a day or two before it started its meteoric rise to the high teens), I am getting 4 times as many shares for the same money, I' liked the concept then and I still think the stock will sell again at few times book value.

Many biotech were decimated, but this one has some time before their burn rate will kill them.

Zeev
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext